Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q4 2022 Earnings Presentation
6 slides from Aurora Cannabis's earnings presentation, Sep 20, 2022
Slide 1: Fiscal Q4 2022 Supplemental Information
FISCAL Q4 2022 SUPPLEMENTAL INFORMATION SEPTEMBER 2022
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Key Takeaways
Key Takeaways Transformation Expect to achieve a positive Adjusted EBITDA run rate exiting December 31, 2022 Plan on Track On track to deliver $150 to $170 million of annualized savings exiting December 31, 2022 Medical #1 Canadian LP in global medical cannabis revenues Leadership Growing in
Slide 4: Q4 2022 Key Financial Highlights
Q4 2022 Key Financial Highlights • Strong Canadian Medical Performance • #1 market share with strong and consistent margins • Direct-to-patient model bypasses provincial distributor • Technology investment drives high and repeatable Non-Core margin and creates barrier to new entrants Canadian Total
Slide 5: FY22 Key Financial Trends
FY22 Key Financial Trends Metric FY22 FY21 YoY Improvement (%) Adjusted Gross Profit Before Fair Value Adjustments, Core $119.0m $117.7m 1% Cannabis(1) Adjusted Gross Margin Before Fair Value Adjustment, Core 54% 48% 13% Cannabis(1) Medical Cannabis Net $162.7m $143.5m 13% Revenue(1) Adjusted EBITDA
Slide 6: Investor Presentation
INVESTOR PRESENTATION Email: aurora@icrinc.com Website: investor.auroramj.com